SBC Medical Group Holdings IncSBCEarnings & Financial Report
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
Revenue
$53.1M
Gross Profit
$39.4M
Operating Profit
$27.3M
Net Profit
$18.5M
Gross Margin
74.2%
Operating Margin
51.4%
Net Margin
34.8%
YoY Growth
N/A
EPS
$0.20
Financial Flow
SBC Medical Group Holdings Inc Q2 2024 Financial Summary
SBC Medical Group Holdings Inc reported revenue of $53.1M for Q2 2024, with a net profit of $18.5M (up 9293.2% YoY) (34.8% margin). Cost of goods sold was $13.7M, operating expenses totaled $12.1M.
Key Financial Metrics
| Total Revenue | $53.1M |
|---|---|
| Net Profit | $18.5M |
| Gross Margin | 74.2% |
| Operating Margin | 51.4% |
| Report Period | Q2 2024 |
SBC Medical Group Holdings Inc Annual Revenue by Year
SBC Medical Group Holdings Inc annual revenue history includes year-by-year totals (for example, 2025 revenue was $173.6M).
| Year | Annual Revenue |
|---|---|
| 2025 | $173.6M |
| 2024 | $205.4M |
SBC Medical Group Holdings Inc Quarterly Revenue & Net Profit History
SBC Medical Group Holdings Inc results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $39.6M | -10.9% | $14.2M | 35.9% |
| Q3 2025 | $43.4M | -18.3% | $12.8M | 29.6% |
| Q2 2025 | $43.4M | -18.3% | $2.5M | 5.7% |
| Q1 2025 | $47.3M | -13.6% | $21.5M | 45.4% |
| Q4 2024 | $44.4M | — | $6.5M | 14.7% |
| Q3 2024 | $53.1M | +12.3% | $2.8M | 5.3% |
| Q2 2024 | $53.1M | — | $18.5M | 34.8% |
| Q1 2024 | $54.8M | — | $18.8M | 34.2% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $54.8M | $53.1M | $53.1M | $44.4M | $47.3M | $43.4M | $43.4M | $39.6M |
| YoY Growth | N/A | N/A | 12.3% | N/A | -13.6% | -18.3% | -18.3% | -10.9% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $19.8M | $19.5M | $296.5M | $266.1M | $284.6M | $315.3M | $321.4M | $380.4M |
| Liabilities | $8.4M | $8.5M | $91.0M | $71.1M | $58.3M | $70.6M | $73.3M | $117.1M |
| Equity | $9.0M | $8.8M | $205.0M | $195.1M | $226.4M | $244.6M | $248.0M | $248.3M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $3.7M | $19.2M | $5.0M | $-7.3M | $1.9M | $-8.3M | $-20.9M | $52.0M |